ISIN | LU1849504649 |
---|---|
No. de valeur | 42469455 |
Bloomberg Global ID | |
Nom de fond | PROTEA - Sectoral Healthcare Opportunities Fund I EUR |
Prestataire de fonds |
Sectoral Asset Management Inc
1010 Sherbrooke St. West, Suite 1610 QC H3A 2R7 Montreal Canada Téléphone: +1 514 849 8777 E-Mail: BusinessDevelopment@sectoral.com |
Prestataire de fonds | Sectoral Asset Management Inc |
Représentant en Suisse |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributeur(s) | |
Classe d'actifs | Fonds en actions |
EFC Catégorie | |
Catégorie de parts | Accumulation |
Pays d'origine | Luxembourg |
Conditions d'émission de parts | Combinaison de commission d'émission en faveur de la direction du fonds et frais de transaction en faveur du fonds |
Conditions de rachat de parts | Combinaison de commission de rachat en faveur de la direction du fonds et frais de transaction en faveur du fonds |
Stratégie d'investissement *** | The Sub-Fund’s investment objective is long-term growth of capital in USD. In order to achieve this objective, the Sub-Fund invests, while respecting the principle of risk diversification, primarily in equities (including, but not limited to, common stocks, preferred stocks, or other securities convertible into common stock) equity-like transferable securities, depositary receipts such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs), participation certificates etc. of small, mid and large cap issuers, located worldwide, in the following healthcare sectors: Healthcare Equipment and Services, Pharmaceuticals, Biotechnology and Lifesciences. |
Particularités |
Prix actuel * | 438.04 EUR | 30.10.2024 |
---|---|---|
Prix précédent * | 444.99 EUR | 29.10.2024 |
Max 52 semaines * | 453.47 EUR | 18.10.2024 |
Min 52 semaines * | 372.56 EUR | 09.11.2023 |
NAV * | 438.04 EUR | 30.10.2024 |
Issue Price * | 438.04 EUR | 30.10.2024 |
Redemption Price * | ||
Closing Price * | ||
Prix minimal indicatif | ||
Actifs du fonds *** | 99'742'379 | |
Actifs de la classe *** | 17'023'770 | |
Trading Information SIX |
YTD Performance | +8.58% |
29.12.2023 - 30.10.2024
29.12.2023 30.10.2024 |
---|---|---|
YTD Performance (en CHF) | +9.98% |
29.12.2023 - 30.10.2024
29.12.2023 30.10.2024 |
1 mois | -0.39% |
30.09.2024 - 30.10.2024
30.09.2024 30.10.2024 |
3 mois | -0.12% |
30.07.2024 - 30.10.2024
30.07.2024 30.10.2024 |
6 mois | +4.76% |
30.04.2024 - 30.10.2024
30.04.2024 30.10.2024 |
1 an | +17.94% |
30.10.2023 - 30.10.2024
30.10.2023 30.10.2024 |
2 ans | +3.63% |
31.10.2022 - 30.10.2024
31.10.2022 30.10.2024 |
3 ans | +3.58% |
02.11.2021 - 30.10.2024
02.11.2021 30.10.2024 |
5 ans | +60.36% |
30.10.2019 - 30.10.2024
30.10.2019 30.10.2024 |
Quota de participation de capital en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Part de la fortune du fonds en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quota d'immobilier en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 8.75% | |
---|---|---|
UnitedHealth Group Inc | 6.89% | |
Novo Nordisk AS Class B | 6.40% | |
AstraZeneca PLC | 4.79% | |
Johnson & Johnson | 3.77% | |
Pfizer Inc | 2.98% | |
Thermo Fisher Scientific Inc | 2.92% | |
AbbVie Inc | 2.80% | |
Boston Scientific Corp | 2.49% | |
Merck & Co Inc | 2.45% | |
Dernière mise à jour des données | 30.09.2024 |
TER | 0.95% |
---|---|
Date TER | 30.06.2023 |
Performance Fee *** | 20.00% |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.92% |
SRRI ***
|
|
Date SRRI *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |